SFX by Ex Libris Inc.

Title:	myo-Inositol:Its Biosynthesis and Metabolism
Source:	Annual Review of Plant Physiology [0066-4294] Loewus, F A yr:1983

Basic

Full text

Full text available via Annual Reviews

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Berry, Gerard T. "In vivo evidence of brain galactitol accumulation in an infant with galactosemia and encephalopathy." The journal of pediatrics 138.2 (2001): 260-262.
description	2.	Culbertson, M R R. "Control of inositol biosynthesis in Saccharomyces cerevisiae: properties of a repressible enzyme system in extracts of wild-type (Ino+) cells." Journal of bacteriology zeyfe.UxBHEQvxhEl (1976): 232-42.
description	3.	Ning, C. "Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week-old animals fed a high-galactose diet." Molecular genetics and metabolism 72.4 (2001): 306-315.
description	4.	BERRY, G. "Galactosemia: When is it a newborn screening emergency?" Molecular genetics and metabolism 106.1 (2012): 7-11.
description	5.	Hirsch, J P. "Expression of the Saccharomyces cerevisiae inositol-1-phosphate synthase (INO1) gene is regulated by factors that affect phospholipid synthesis." Molecular and cellular biology 6.10 (1986): 3320-3328.
description	6.	Cakmakci, H. "Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature." European Journal of Radiology 74.3 (2009): -71.
description	7.	Berry, G. "The role of polyols in the pathophysiology of hypergalactosemia." European journal of pediatrics 154.7 (1995): 53-64.
description	8.	Ridel, Keith R R. "An updated review of the long-term neurological effects of galactosemia." Pediatric neurology 33.3 (2005): 153-61.
description	9.	Ryan, Emily L. "Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia." Journal of inherited metabolic disease 36.6 (2013): 1049-1061.
description	10.	Tsakiris, S. "The in vitro effects of galactose and its derivatives on rat brain Mg2+ATPase activity." Pharmacology & toxicology (2002): 254-257.
description	11.	Forges, T. "Pathophysiology of impaired ovarian function in galactosaemia." Human reproduction update 12.5 (2006): 573-84.
description	12.	Yager, C. "Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency." Pediatric research 48.2 (2000): 211-217.
description	13.	Bhat, A. "Expression of human inositol monophosphatase suppresses galactose toxicity in Saccharomyces cerevisiae: possible implications in galactosemia." Biochimica et biophysica acta 1454.3 (1999): 217-26.
description	14.	Lai, K. "Galactose toxicity in animals." IUBMB life 61.11 (2009): 1063-1074.
description	15.	Elsea, Sarah H. "The mousetrap: what we can learn when the mouse model does not mimic the human disease." ILAR journal 43.2 (2002): 66-79.
description	16.	Wolff, F R R. "A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine." Journal of inherited metabolic disease 20.4 (1997): 549-55.
description	17.	Panis, B. "Bone metabolism in galactosemia." Bone 35.4 (2004): 982-7.
description	18.	Bosch, A M M. "[From gene to disease; galactosemia and galactose-1-phosphate uridyltransferase deficiency]." Nederlands tijdschrift voor geneeskunde 148.2 (2003): 80-1.
description	19.	Bosch, Annet M M. "Classical galactosaemia revisited." Journal of inherited metabolic disease 29.4 (2006): 516-25.
description	20.	Zlatunich, C O O. "Galactosaemia: early treatment with an elemental formula." Journal of inherited metabolic disease 28.2 (2005): 163-8.